Follow
Kevin Watanabe-Smith
Kevin Watanabe-Smith
Verified email at ohsu.edu
Title
Cited by
Cited by
Year
Functional genomic landscape of acute myeloid leukaemia
JW Tyner, CE Tognon, D Bottomly, B Wilmot, SE Kurtz, SL Savage, ...
Nature 562 (7728), 526-531, 2018
10302018
An expanded universe of cancer targets
WC Hahn, JS Bader, TP Braun, A Califano, PA Clemons, BJ Druker, ...
Cell 184 (5), 1142-1155, 2021
1532021
Fancd2 −/− mice have hematopoietic defects that can be partially corrected by resveratrol
QS Zhang, L Marquez-Loza, L Eaton, AW Duncan, DC Goldman, P Anur, ...
Blood, The Journal of the American Society of Hematology 116 (24), 5140-5148, 2010
1062010
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells
DK Edwards, K Watanabe-Smith, A Rofelty, A Damnernsawad, T Laderas, ...
Blood, The Journal of the American Society of Hematology 133 (6), 588-599, 2019
962019
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance
SK Joshi, T Nechiporuk, D Bottomly, PD Piehowski, JA Reisz, ...
Cancer cell 39 (7), 999-1014. e8, 2021
692021
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms
SK Joshi, K Qian, WH Bisson, K Watanabe-Smith, A Huang, D Bottomly, ...
Blood, The Journal of the American Society of Hematology 135 (24), 2159-2170, 2020
272020
Gain-of-function mutations in granulocyte colony–stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation
H Zhang, C Coblentz, K Watanabe-Smith, S Means, J Means, JE Maxson, ...
Journal of Biological Chemistry 293 (19), 7387-7396, 2018
262018
Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia
K Watanabe-Smith, C Tognon, JW Tyner, JPP Meijerink, BJ Druker, ...
Leukemia 30 (9), 1950-1953, 2016
252016
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
TP Braun, M Okhovat, C Coblentz, SA Carratt, A Foley, Z Schonrock, ...
Nature communications 10 (1), 5455, 2019
242019
Evaluation of resveratrol and N‐acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model
QS Zhang, L Marquez‐Loza, AM Sheehan, K Watanabe‐Smith, L Eaton, ...
Pediatric blood & cancer 61 (4), 740-742, 2014
212014
Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations
K Watanabe-Smith, J Godil, A Agarwal, C Tognon, B Druker
Oncotarget 8 (8), 12596, 2017
142017
Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice
QS Zhang, K Watanabe-Smith, K Schubert, A Major, AM Sheehan, ...
Stem cell research 11 (2), 687-692, 2013
142013
Unpaired extracellular cysteine mutations of CSF3R mediate gain or loss of function
H Zhang, S Means, AR Schultz, K Watanabe-Smith, BC Medeiros, ...
Cancer research 77 (16), 4258-4267, 2017
132017
Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients
MW Rosenberg, K Watanabe-Smith, JW Tyner, CE Tognon, BJ Druker, ...
Oncotarget 11 (29), 2807, 2020
62020
Exome sequencing informs mechanisms of clinical resistance to the FLT3-D835 inhibitor crenolanib
H Zhang, KM Watanabe-Smith, D Bottomly, B Wilmot, SK McWeeney, ...
Blood 126 (23), 2468, 2015
52015
Factors Predicting Response and Resistance to Midostaurin in FLT3 Positive and FLT3 Negative AML in 483 Primary AML Patient Samples
K Watanabe-Smith, M Rosenberg, T Bucy, JW Tyner, U Borate
Blood 130, 296, 2017
22017
Critical Role Of Interleukin Receptor Signaling In Acute Myeloid Leukemia Identified Using An RNAi Functional Screen
A Agarwal, RJ Meckenzie, A Carey, M Davare, CA Eide, ...
Blood 122 (21), 473, 2013
22013
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
TP Braun, M Okhovat, C Coblentz, SA Carratt, A Foley, Z Schonrock, ...
Nature communications 13, 2022
12022
RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples
M Rosenberg, CE Tognon, KM Watanabe-Smith, U Borate
Blood 132, 1365, 2018
12018
Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia
K Watanabe-Smith, BJ Druker, JW Tyner, DK Edwards
haematologica 103 (8), e351, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20